New York, NY · Founded 2022 · Privately Held (backing)
Provider of molecular diagnostic kits intended to enhance the accuracy and timeliness of disease detection. Reme-D is based in New York, NY and was founded in 2022. Its last reported valuation was $330,000 in May 2024. It has raised $520,000.
Last reported valuation
$330K
Oct 2026
Priced at
—
Total raised
$520K
Last round
—
Cap table — not yet on record
Reme-D's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Reme-D with a free account
·Watch Reme-D: the Monday email on marks, rounds and moves
